A detailed history of Covestor LTD transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Covestor LTD holds 7 shares of DAWN stock, worth $96. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 7 -0.0%
Holding current value
$96
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$13.56 - $17.46 $13 - $17
-1 Reduced 12.5%
7 $0
Q4 2023

Feb 09, 2024

SELL
$9.68 - $15.37 $9 - $15
-1 Reduced 11.11%
8 $0
Q3 2023

Nov 13, 2023

SELL
$11.22 - $14.86 $11 - $14
-1 Reduced 10.0%
9 $0
Q2 2023

Aug 11, 2023

BUY
$11.74 - $14.47 $46 - $57
4 Added 66.67%
10 $0
Q3 2022

Nov 14, 2022

BUY
$16.44 - $26.57 $98 - $159
6 New
6 $0

Others Institutions Holding DAWN

About Day One Biopharmaceuticals, Inc.


  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $1.01B
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.